Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
D000208:Acute Disease; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003091:Colistin / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D017053:Infection Control; D007938:Leukemia / Q000150:complications*; D009355:Neomycin / Q000627:therapeutic use; D009503:Neutropenia / Q000150:complications; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D000890:Anti-Infective Agents; D004338:Drug Combinations; D002939:Ciprofloxacin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D009355:Neomycin; D013420:Sulfamethoxazole; D003091:Colistin